Study of related factors in symptoms of adult attention-deficit/hyperactivity disorder
Not Applicable
- Conditions
- adult attention-deficit/hyperactivity disorder
- Registration Number
- JPRN-UMIN000050196
- Lead Sponsor
- Kwansei University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 1017
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint is the difference in the effects of the WURS score, ECR-GO score, and PBI score on the presence or absence of adult ADHD symptoms.
- Secondary Outcome Measures
Name Time Method Secondary endpoints are comparisons and studies of relationships among measures such as ASRS score, WURS score, ECR-GO score, PBI score, PHQ-9 score, and busyness questionnaire scores.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie adult ADHD symptom persistence identified in JPRN-UMIN000050196?
How do dopaminergic and serotonergic pathways correlate with ADHD severity in this meta-analysis?
Which biomarkers predict treatment response in adult ADHD patients with comorbid anxiety or depression?
What adverse events are associated with long-term ADHD pharmacotherapy in Japanese population studies?
How does JPRN-UMIN000050196 compare to methylphenidate/atomoxetine trials in adult ADHD subtypes?